These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3288852)

  • 1. [Cytokines. Basic research as the basis for therapeutic innovations].
    Uhl D
    Med Monatsschr Pharm; 1988 Apr; 11(4):147-50. PubMed ID: 3288852
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological Response Modifiers Programme and cancer chemotherapy.
    Oldham RK
    Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotechnology products in cancer therapy: a colloquium.
    Borden EC; Bradley EC; Evans CH; Fox CF; Metzgar RS; Mitchell MS; Weinstein JN
    Cancer Res; 1988 Jan; 48(1):223-5. PubMed ID: 3275492
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer nursing: biological therapy.
    Moore J
    Nursing (Lond); 1990 Aug 23-Sep 12; 4(17):20-2. PubMed ID: 2234587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological therapies of systemic lupus erythematosus].
    Olesińska M; Chwalińska-Sadowska H; Mielnik P; Wiesik-Szewczyk E
    Pol Merkur Lekarski; 2006 Mar; 20(117):371-3. PubMed ID: 16780279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Present status of studies on the application of immunology to the diagnosis and therapy of cancer, with emphasis on monoclonal antibodies and cytokines].
    Tokunaga T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1358-66. PubMed ID: 3296954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel biologic approaches to the treatment of rheumatoid arthritis.
    Sany J
    Rev Rhum Engl Ed; 1999 Nov; 66(11):548-59. PubMed ID: 10591116
    [No Abstract]   [Full Text] [Related]  

  • 8. Smart weapons.
    Kraco K
    Minn Med; 2004 May; 87(5):28-32. PubMed ID: 15191065
    [No Abstract]   [Full Text] [Related]  

  • 9. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targets for rheumatoid arthritis.
    Keystone EC; Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():1. PubMed ID: 19509323
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic praxis with cultures of physiological bacteria and special antigens].
    KOLB H
    Hippokrates; 1954 Nov; 25(21):671-5. PubMed ID: 13232588
    [No Abstract]   [Full Text] [Related]  

  • 12. Biologicals and biological response modifiers: design of clinical trials.
    Oldham RK
    J Biol Response Mod; 1985 Apr; 4(2):117-28. PubMed ID: 3889226
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse side-effects to biological agents.
    Pichler WJ
    Allergy; 2006 Aug; 61(8):912-20. PubMed ID: 16867042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activities of natural triterpenoids and their therapeutic implications.
    Dzubak P; Hajduch M; Vydra D; Hustova A; Kvasnica M; Biedermann D; Markova L; Urban M; Sarek J
    Nat Prod Rep; 2006 Jun; 23(3):394-411. PubMed ID: 16741586
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current and alternative therapeutic methods in bronchial carcinoma].
    Dold U
    Prax Klin Pneumol; 1987 Oct; 41 Suppl 1():730-4. PubMed ID: 3432221
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology in the era of biotherapeutics.
    Lalonde RL; Honig P
    Clin Pharmacol Ther; 2008 Nov; 84(5):533-6. PubMed ID: 18941451
    [No Abstract]   [Full Text] [Related]  

  • 17. [Composition and use of bacterial cultures for therapeutic purposes].
    Reuter G
    Arzneimittelforschung; 1969 Jan; 19(1):103-9. PubMed ID: 4978159
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologicals and biological response modifiers: fourth modality of cancer treatment.
    Oldham RK
    Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic experience with omnacillin forte during the influenza epidemic 1952-53].
    GREIF S
    Munch Med Wochenschr; 1954 Aug; 96(34):947-8. PubMed ID: 13203544
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new therapeutic alternative for the treatment of enteritis--controlled double-blind tests with the strain SF 68].
    Bruno F; Frigerio G
    Schweiz Rundsch Med Prax; 1981 Sep; 70(39):1717-20. PubMed ID: 6792618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.